Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Moodys
Julphar
Federal Trade Commission
US Army
Citi
Accenture
Johnson and Johnson
McKinsey
McKesson

Generated: October 22, 2017

DrugPatentWatch Database Preview

ZOSYN Drug Profile

« Back to Dashboard

What is the patent landscape for Zosyn, and when can generic versions of Zosyn launch?

Zosyn is a drug marketed by Wyeth Pharms Inc and is included in two NDAs. There are four patents protecting this drug and two Paragraph IV challenges.

This drug has forty-one patent family members in thirty-three countries.

The generic ingredient in ZOSYN is piperacillin sodium; tazobactam sodium. There are fourteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.

Summary for Tradename: ZOSYN

US Patents:3
Applicants:1
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list46
Clinical Trials: see list8
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZOSYN at DailyMed

Pharmacology for Tradename: ZOSYN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc
ZOSYN
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION050684-001Oct 22, 1993APRXYesYes► Subscribe► SubscribeY ► Subscribe
Wyeth Pharms Inc
ZOSYN IN PLASTIC CONTAINER
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION050750-001Feb 24, 1998RXYesYes► Subscribe► SubscribeY ► Subscribe
Wyeth Pharms Inc
ZOSYN IN PLASTIC CONTAINER
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION050750-002Feb 24, 1998RXYesYes► Subscribe► SubscribeY ► Subscribe
Wyeth Pharms Inc
ZOSYN
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION050684-003Oct 22, 1993APRXYesYes► Subscribe► SubscribeY ► Subscribe
Wyeth Pharms Inc
ZOSYN
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION050684-002Oct 22, 1993APRXYesYes► Subscribe► SubscribeY ► Subscribe
Wyeth Pharms Inc
ZOSYN
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION050684-004Oct 22, 1993APRXYesYes► Subscribe► SubscribeY ► Subscribe
Wyeth Pharms Inc
ZOSYN IN PLASTIC CONTAINER
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION050750-001Feb 24, 1998RXYesYes► Subscribe► SubscribeY ► Subscribe
Wyeth Pharms Inc
ZOSYN
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION050684-003Oct 22, 1993APRXYesYes► Subscribe► SubscribeY ► Subscribe
Wyeth Pharms Inc
ZOSYN IN PLASTIC CONTAINER
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION050750-001Feb 24, 1998RXYesYes► Subscribe► SubscribeY ► Subscribe
Wyeth Pharms Inc
ZOSYN IN PLASTIC CONTAINER
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION050750-003Feb 24, 1998RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for ZOSYN

Drugname Dosage Strength RLD Submissiondate
piperacillin sodium and tazobactam sodiumFor Injection12 g/1.5 g per vial (pharmacy bulk)Zosyn12/6/2011
piperacillin sodium and tazobactam sodiumFor Injection2.25 g/vial, 3.375 g/vial, 4.5 g/viaZosynPIV received prior to 2/5/2009

Non-Orange Book Patents for Tradename: ZOSYN

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,498,312Compositions containing piperacillin and tazobactam useful for injection► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: ZOSYN

Country Document Number Estimated Expiration
Russian Federation2005135135► Subscribe
EcuadorSP056100► Subscribe
TaiwanI308069► Subscribe
Argentina043863► Subscribe
Colombia5700796► Subscribe
Taiwan200503758► Subscribe
Hong Kong1069775► Subscribe
BrazilPI0409450► Subscribe
Denmark1468697► Subscribe
Slovenia1468697► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Fuji
Fish and Richardson
US Department of Justice
US Army
QuintilesIMS
Colorcon
Cerilliant
Chinese Patent Office
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot